Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Primary Target | Pathway | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|---|---|
| PDXHCI002 | Cisplatin | 1.0 | Chemo | Chemotherapy | 0.6445 | -0.07108 |
| HCC1500 | Etoposide | 0.31623 | Topo II | Chemotherapy | 0.9236 | -0.07287 |
| PDXHCI002 | Topotecan | 0.0033333 | Topo I | Chemotherapy | 0.7862 | -0.07478 |
| PDXHCI002 | Bleomycin | 0.31623 | Radiation | Misc | 0.7964 | -0.08259 |
| HCC1500 | Etoposide | 1.0 | Topo II | Chemotherapy | 0.5931 | -0.08322 |
| PDXHCI002 | Etoposide | 0.1 | Topo II | Chemotherapy | 0.6449 | -0.08531 |
| PDXHCI002 | Bleomycin | 1.0 | Radiation | Misc | 0.5681 | -0.08965 |
| HCC1500 | Topotecan | 0.0033333 | Topo I | Chemotherapy | 0.5954 | -0.09112 |
| PDXHCI002 | Cisplatin | 3.1623 | Chemo | Chemotherapy | 0.2841 | -0.09181 |
| PDXHCI002 | Etoposide | 0.31623 | Topo II | Chemotherapy | 0.3668 | -0.10135 |